Smith Group Asset Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Smith Group Asset Management’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-6,140	Closed	-$152K	–	505
2016 Q2	$152K	Buy	6,140 +2,512	+69%	+$71K	﹤0.01%	288
2016 Q1	$105K	Buy	3,628 +867	+31%	+$23.5K	﹤0.01%	269
2015 Q4	$102K	Buy	2,761 +288	+12%	+$12.7K	﹤0.01%	292
2015 Q3	$120K	Buy	2,473 +68	+3%	+$4.75K	﹤0.01%	244
2015 Q2	$166K	Buy	+2,405	New	+$111K	0.01%	227

Other funds holding ANTH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

PAI

ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Smith Group Asset Management's ANTH Position: Q3 2016 in Review

Smith Group Asset Management sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q3 2016, closing a stake of 6,140 shares — an estimated $152K sold.

Smith Group Asset Management first reported a position in ANTH in Q2 2015 and held it in 5 quarters. The position peaked at $166K in Q2 2015. 72 funds tracked by Wall St. Rank hold ANTH as of Q3 2016.

Smith Group Asset Management reported no remaining Anthera Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
Smith Group Asset Management sold 6,140 Anthera Pharmaceuticals, Inc. shares in Q3 2016, an estimated $152K.
Smith Group Asset Management first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2015 and held it in 5 quarters.
Smith Group Asset Management's Anthera Pharmaceuticals, Inc. position peaked at $166K in Q2 2015.
72 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q3 2016.

Based on Smith Group Asset Management's 13F filing for Q3 2016, filed 2 Nov 2016.